MYCBP2 and Splenomegaly: The percentage of patients exhibiting splenomegaly and liver infiltration was significantly higher in the low MYCBP2 expression group than in the high expression group (54.3% vs 35.9%, P = 0.033; 35.7% vs 15.4%, P = 0.007) (Supplemental Table 2).